I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
If you are not a healthcare professional and you want to learn about contraception please click below.
If you are not a healthcare professional and you want to learn about heavy menstural bleedingplease click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

PHE: Public health indicators to include LARC prescribing

06 November 2019

The Public Health Outcomes Framework (PHOF) provides an overview of national and local public health measures, intended to serve as a guidance for health authorities.

Following a consultation launched in early 2019, the prescribing of LARC has been included among the recommended new indicators within the PHOF. The benchmarking tool is intended to support transparency and accountability, and is reviewed every 3 years, with the newest iteration taking effect 2019/20.

The indicator will measure “Total prescribed long-acting reversible contraception (LARC) (excluding injection) rate per 1,000 females aged 15-44”. This aligns to the PHE’s Public Health Dashboard on sexual and reproductive health indicators.

Recommendations

Online learning

Read more

Upcoming webinars

Read more

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0285 November 2019

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Tue, 06/02/2020 - 05:20

Bayer logo